GOG Foundation
Avatar

Frontline Maintenance Therapy With PARPi is the Standard of Care in Ovarian Cancer: Why Is Rebuttal Even Needed?

By GOG Foundation FEATURING Kathleen Moore
By GOG Foundation FEATURING Kathleen Moore
183 views
January 22, 2020
0 Comments
Login to view comments. Click here to Login

Featured Video

17:33
AstraZeneca Oncology

First-line Maintenance Therapy for BRCAm Advanced Ovarian Cancer Fol…

Feat. S. Lewin

Featured Video

20:09
AstraZeneca Oncology

Management Strategies for Anemia in First-line Maintenance Therapy f…

Feat. D. Czel, C. Arn

Related Content

AUTOPLAY
06:07
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Summary: "Key Updates in Gynecological Cancers"

Feat. M. Raza Mirza
06:47
UCSF School of Medicine

Tumor-Agnostic Efficacy & Safety of Selpercatinib in RET Fusion+…

Feat. H. Kang
06:50
Fengting Yan

Year in Review: Ovarian Cancer

25:10
Yale School of Medicine

Ovarian Cancer Prevention and Early Detection - Ovarian Cancer Does …

Feat. M. Minkin, E. Ratner
06:23
Total Health

Recent Highlights in Ovarian Cancer

Feat. B. Slomovitz
18:16
Insights from 2024 ESGO Annual Meeting

ESGO 2024 Insights: "Antibody-Drug Conjugates in Ovarian Cancer…

Feat. J. Kurtz
05:09
Insights from 2024 SGO Annual Meeting

SGO 2024 Insights: "Final OS Data of Relacorilant, a Selective …

Feat. N. Colombo
23:35
Kathleen Moore

How to Select the Best Maintenance Treatment in Patients With Ovaria…

09:42
Erin Crane

Niraparib as 1L Maintenance Treatment for Advanced Ovarian Cancer

17:06
Ovarian Cancer Midwest Focus, University of Minnesota

Novel ADCs in Ovarian Cancer: A New Treatment Modality

Feat. S. Lheureux
08:37
Fred Hutchinson Cancer Center

Niraparib as 1L Maintenance Treatment for Advanced Ovarian Cancer: D…

Feat. K. Banda
24:12
Jubilee Brown

Rare Ovarian Cancer: Epithelial Tumors

08:19
Insights from 2023 ESGO Annual Meeting

ESGO 2023 Insights: "Final OS and Long-Term Safety in the ENGOT…

Feat. M. Raza Mirza
13:58
ISCO - International School of Clinical Oncology

Novel Therapies and Combinations in Ovarian Cancer

Feat. A. Leary
28:26
Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2023

The Role of Immunotherapy and Targeted Therapy in GYN Cancers

Feat. S. Gaillard
18:57
ESMO 2022 Conference Coverage

ESMO 2022: Should All Advanced Ovarian Cancer Patients Receive a PAR…

Feat. D. Tan
11:32
SGO 2023 Conference Coverage on VuMedi

SGO 2023 GOG 3026 Phase II Trial of Letrozole + Ribociclib in Women …

Feat. B. Slomovitz
13:04
Nebraska Oncology Society

Updates in Ovarian Cancer: Risk Reduction Strategies and Mirvetuxima…

Feat. M. Clark
23:46
AstraZeneca Oncology

First-line Maintenance Treatment Option in Patients With HRD-Positiv…

Feat. S. Lewin
17:06
2023 Evolution Conference

Genetic Testing in Early and Recurrent Ovarian Cancer

Feat. J. Barr